Brain cell type–specific enhancer–promoter interactome maps and disease <b>-</b> risk association
2019 · Science · 747 citations
https://doi.org/10.1126/science.aay0793
R
Robert A. Rissman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
422
Papers
20.3K
Citations
71
h-index
188
i10-index
Robert A. Rissman is an academic researcher from University of California San Diego. The author has contributed to research in topics: Alzheimer's disease research and treatments & Dementia and Cognitive Impairment Research & Neuroinflammation and Neurodegeneration Mechanisms. The author has an h-index of 71, co-authored 359 publications.
ORCID: 0000-0001-9245-8278Papers by this author
worksPerspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
2018 · Alzheimer s & Dementia · 529 citations
https://doi.org/10.1016/j.jalz.2018.09.009
The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease
2020 · Nature · 373 citations
https://doi.org/10.1038/s41586-020-2681-2
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
2020 · JAMA Neurology · 339 citations
https://doi.org/10.1001/jamaneurol.2020.1840
Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research
2014 · Alzheimer s & Dementia · 274 citations
https://doi.org/10.1016/j.jalz.2014.08.099
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
2022 · Acta Neuropathologica · 219 citations
https://doi.org/10.1007/s00401-022-02408-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat